Familial Adenomatous Polyposis (FAP)
Syndrome
Gardner
Syndrome
Epidemiology and
Etiology:
·
APC mutations (5q21) (90%)
·
Deletions in 8-12%
·
subtypes:
·
Classic (500-2500 colonic adenomas)
·
Minimum 100 polyps in colon
·
Cancer risk 100%
·
Attenuated (average 30 polyps)
·
Most in proximal colon
·
Cancer risk 50%
·
Gardner
·
Classic FAP + lesions at other sites (listed below)
·
Turcot
·
Colonic polyposis + CNS tumours
·
2/3 have APC mutations
·
1/3 have HNPCC
·
Common sites:
·
Colon
·
Polyposis (> 100)
·
Adenocarcinoma
·
39 y mean age in untreated individuals
·
ganglioneuroma
·
Small bowel
·
Ampulla of Vater
·
Adenoma
·
Adenocarcinoma
·
Stomach
·
Adenoma
·
Fundic gland polyp
·
Adenocarcinoma
·
Bone (mandible, skull, long bones)
·
Osteoma
·
Skin
·
Epidermal cyst
·
Pilomatricoma
·
Soft Tissue
·
Fibromatosis
·
Thyroid
·
Carcinoma
·
CNS
·
Medulloblastoma
·
Liver
·
Hepatoblastoma
·
Congenital hypertrophy of the retinal pigment epithelium (CHRPE)
Gross features:
·
Histologic
features:
·
GI polyps:
·
Vast majority are tubular adenomas
Immunophenotype:
Marker: |
Sensitivity: |
Specificity: |
|
|
|
Molecular features:
·
APC full gene sequencing is available
·
Most accurate test – sensitivity <=90%
·
MLPA or qPCR or SB for deletions
Other features:
·
Colectomy advised when more
than 20-30 adenomas with “advanced histology” have occurred
·
Polypectomy recommended for
adenomas with
·
> 1cm
·
Villous
·
Severe dysplasia
·
Symptomatic
·
NSAIDs, particularly sulindac, may
cause decrease in number of polyps
References:
·
Kumar V, Fausto N, Abbas
A. Robbins & Cotran Pathologic Basis of Disease,
Seventh Edition. 7th ed. Saunders; 2004.
·
Genetests.org